The effects of tri-aryl phosphates upon cholinesterase.
D000284:Administration, Oral; D000818:Animals; D001921:Brain / Q000201:enzymology; D002415:Cats; D002645:Chickens; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D002802:Cholinesterases / Q000097:blood* / Q000378:metabolism; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D007274:Injections, Intraperitoneal; D008297:Male; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013045:Species Specificity; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D009943:Organophosphorus Compounds; D002802:Cholinesterases